- Home
- CDXS
CDXS
Codexis Inc.
as of 02-24-2026 3:46pm EST
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 141.8M | IPO Year: | 2008 |
| Target Price: | N/A | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.62 | EPS Growth: | 20.54 |
| 52 Week Low/High: | $1.05 - $4.30 | Next Earning Date: | 01-01-0001 |
| Revenue: | $138,590,000 | Revenue Growth: | 32.30% |
| Revenue Growth (this year): | 15.64% | Revenue Growth (next year): | 5.23% |
| P/E Ratio: | -1.71 | Index: | N/A |
| Free Cash Flow: | -53715000.0 | FCF Growth: | N/A |
AI-Powered CDXS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Codexis Inc. (CDXS)
See Remarks
Avg Cost/Share
$1.31
Shares
3,826
Total Value
$5,000.96
Owned After
66,810
SEC Form 4
President and CEO
Avg Cost/Share
$1.31
Shares
3,826
Total Value
$5,000.96
Owned After
250,506
SEC Form 4
Chief Scientific Officer
Avg Cost/Share
$1.31
Shares
2,492
Total Value
$3,257.29
Owned After
136,283
SEC Form 4
CSO
Avg Cost/Share
$1.70
Shares
4,685
Total Value
$7,949.51
Owned After
136,283
SEC Form 4
10% Owner
Avg Cost/Share
$1.67
Shares
253,533
Total Value
$422,766.28
Owned After
9,955,000
10% Owner
Avg Cost/Share
$1.75
Shares
107,490
Total Value
$188,107.50
Owned After
9,955,000
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Erbez Georgia | CDXS | See Remarks | Feb 6, 2026 | Sell | $1.31 | 3,826 | $5,000.96 | 66,810 | |
| MOORE ALISON | CDXS | President and CEO | Feb 6, 2026 | Sell | $1.31 | 3,826 | $5,000.96 | 250,506 | |
| Lutz Stefan | CDXS | Chief Scientific Officer | Feb 6, 2026 | Sell | $1.31 | 2,492 | $3,257.29 | 136,283 | |
| Lutz Stefan | CDXS | CSO | Jan 7, 2026 | Sell | $1.70 | 4,685 | $7,949.51 | 136,283 | |
| Opaleye Management Inc. | CDXS | 10% Owner | Dec 1, 2025 | Sell | $1.67 | 253,533 | $422,766.28 | 9,955,000 | |
| Opaleye Management Inc. | CDXS | 10% Owner | Nov 28, 2025 | Sell | $1.75 | 107,490 | $188,107.50 | 9,955,000 |
Compare CDXS vs Leading Stocks
See how CDXS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CDXS Codexis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.